MétaCan
Menu
Back to cohort
Record W2068523052 · doi:10.1038/nature12965

Comprehensive molecular characterization of urothelial bladder carcinoma

2014· article· en· W2068523052 on OpenAlexaff
John N. Weinstein, Xiaoping Su, Nianxiang Zhang, Wenyi Wang, Bradley M. Broom, Zhenlin Ju, Jiexin Zhang, Michael T. Ryan, Thomas Motter, Hui Yao, Wenbin Liu, Philip L. Lorenzi, Rehan Akbani, Roeland Verhaak, Bo Peng, Gordon B. Mills, David J. McConkey, Weiguo Jian, Richard C. Gibbs, Seth P. Lerner, Patricia Garrido Castro, Whitney D. McClenden, Margaret Morgan, Chad J. Creighton, Lawrence A. Donehower, C. Smith, Gordon Saksena, Lee Lichtenstein, Michael S. Lawrence, Carrie Sougnez, Kristian Cibulskis, Petar Stojanov, Steven E. Schumacher, Doug Voet, Yingchun Liu, Jaegil Kim, Pei Lin, Hailei Zhang, Scott L. Carter, Scott Frazer, Michael S. Noble, Daniel DiCara, Lihua Zou, Nils Gehlenborg, David I. Heiman, Juok Cho, Rameen Beroukhim, David J. Kwiatkowski, Ami S. Bhatt, Andrey Sivachenko, Joonil Jung, Chip Stewart, Andrew D. Cherniack, Samuel S. Freeman, Eric Lander, Tod D. Casasent, Chandra Sekhar Pedamallu, Ashley Marie Regazzi, Jonathan E. Rosenberg, Hikmat Al‐Ahmadie, Ilana Garcia-Grossman, Victor E. Reuter, Bernard H. Bochner, David B. Solit, Theresa M. Koppie, Brian D. Robinson, David C. Fargo, Dmitry A. Gordenin, Steven A. Roberts, Leszek J. Klimczak, Jessie L.‐S. Au, David Van Den Berg, Daniel J. Weisenberger, Timothy J. Triche, Phillip H. Lai, Peter W. Laird, Hui Shen, Toshinori Hinoue, Marc Ladanyi, William Lee, Rileen Sinha, Ricardo Ramírez, Nils Weinhold, Yevgeniy Antipin, Bülent Arman Aksoy, Jianjiong Gao, S. Onur Sumer, Gideon Dresdner, Chris Sander, Nikolaus Schultz, Benjamin E. Gross, Ronglai Shen, Giovanni Ciriello, Boris Reva, Donna E. Hansel, Lisle E. Mose, D. Neil Hayes, Tom Bodenheimer, Janae V. Simons, Junyuan Wu, Joel S. Parker, Katherine A. Hoadley, William Y. Kim, Mathew G. Soloway, Shaowu Meng, Saianand Balu, Charles M. Perou, Matthew D. Wilkerson, Stephen B. Baylin, Gad Getz, Matthew Meyerson, Adrian Ally, Payal Sipahimalani, Steven J.M. Jones, Nina Thiessen, Jacqueline E. Schein, A. Gordon Robertson, Natasja Wye, Richard A. Moore, Andrew J. Mungall, Yaron S.N. Butterfield, Robert A. Holt, Miruna Balasundaram, Marco A. Marra, Ranabir Guin, Angela Tam, Eric Chuah, Noreen Dhalla, Tina Wong, Haiyan I. Li, Reanne Bowlby, Carrie Hirst, Darlene Lee, Jeffrey Roach, Corbin D. Jones, Elizabeth Buda, Donghui Tan, Piotr A. Mieczkowski, Umadevi Veluvolu, J. Todd Auman, Xiaojia Ren, Angeliki Pantazi, Michael Parfenov, Angela Hadjipanayis, Netty Santoso, Jonathan G. Seidman, Peter J. Park, Andrew Wei Xu, Lixing Yang, Semin Lee, Jiabin Tang, Xingzhi Song, Sahil Seth, Christopher A. Bristow, Jianhua Zhang, Dong Zeng, Lynda Chin, Alexei Protopopov, Harshad S. Mahadeshwar, Kenneth Aldape, Jolanta Bondaruk, Charles C. Guo, Dick Kreisberg, Ilya Shmulevich, Brady Bernard, Sheila M. Reynolds, Hector Rovira, Christopher C. Benz, Joshua M. Stuart, Jing Zhu, Sam Ng, David Haussler, Yuexin Liu, Wei Zhang, Barry S. Taylor, Nilsa C. Ramirez, Carmen Helsel, Teresa R. Tabler, Thomas Barr, Stephanie Weaver, Tara M. Lichtenberg, Aaron D. Black, Benjamin Hanf, Lisa Wise, Myra M. George, Erik Zmuda, Jay Bowen, Cynthia McAllister, Katherine Tarvin, Charles Saller

Bibliographic record

VenueNature · 2014
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsSt. Joseph’s Healthcare HamiltonCanada's Michael Smith Genome Sciences CentreUniversity of British Columbia
FundersLineberger Comprehensive Cancer Center, University of North Carolina at Chapel HillNational Center for Advancing Translational SciencesNational Cancer InstituteNational Human Genome Research InstituteMassachusetts Institute of TechnologyDan L. Duncan Cancer Center, Baylor College of MedicineSchool of Medicine, Indiana UniversityUniversity of California, San DiegoNational Heart, Lung, and Blood InstituteUniversity of Texas MD Anderson Cancer CenterNational Institutes of HealthSylvester Comprehensive Cancer Center, University of Miami Health SystemsBrigham and Women's HospitalUniversity of North Carolina at Chapel HillBroad InstituteNational Institute of Dental and Craniofacial ResearchResearch Institute, Nationwide Children's HospitalMemorial Sloan-Kettering Cancer CenterUniversity of Texas Southwestern Medical CenterCleveland Clinic FoundationCleveland ClinicUniversity of ChicagoHarvard UniversityUniversity of PittsburghNationwide Children's HospitalSRA InternationalUniversity of Miami
KeywordsCancer researchBiologymicroRNAChromatinGeneTargeted therapyPI3K/AKT/mTOR pathwayCancerGeneticsSignal transduction

Abstract

fetched live from OpenAlex

Urothelial carcinoma of the bladder is a common malignancy that causes approximately 150,000 deaths per year worldwide. So far, no molecularly targeted agents have been approved for treatment of the disease. As part of The Cancer Genome Atlas project, we report here an integrated analysis of 131 urothelial carcinomas to provide a comprehensive landscape of molecular alterations. There were statistically significant recurrent mutations in 32 genes, including multiple genes involved in cell-cycle regulation, chromatin regulation, and kinase signalling pathways, as well as 9 genes not previously reported as significantly mutated in any cancer. RNA sequencing revealed four expression subtypes, two of which (papillary-like and basal/squamous-like) were also evident in microRNA sequencing and protein data. Whole-genome and RNA sequencing identified recurrent in-frame activating FGFR3–TACC3 fusions and expression or integration of several viruses (including HPV16) that are associated with gene inactivation. Our analyses identified potential therapeutic targets in 69% of the tumours, including 42% with targets in the phosphatidylinositol-3-OH kinase/AKT/mTOR pathway and 45% with targets (including ERBB2) in the RTK/MAPK pathway. Chromatin regulatory genes were more frequently mutated in urothelial carcinoma than in any other common cancer studied so far, indicating the future possibility of targeted therapy for chromatin abnormalities. This paper reports integrative molecular analyses of urothelial bladder carcinoma at the DNA, RNA, and protein levels performed as part of The Cancer Genome Atlas project; recurrent mutations were found in 32 genes, including those involved in cell-cycle regulation, chromatin regulation and kinase signalling pathways; chromatin regulatory genes were more frequently mutated in urothelial carcinoma than in any other common cancer studied so far. This study of 131 high-grade muscle-invasive urothelial bladder carcinomas, part of The Cancer Genome Atlas (TCGA) project, reports recurrent mutations in 32 genes, including those involved in cell-cycle regulation, chromatin regulation and kinase signalling pathways. Chromatin regulatory genes were more frequently mutated in urothelial carcinoma than in any common cancer studied to date. Recurrent in-frame activating FGFR3–TACC3 fusions and expression or integration of viruses associated with gene inactivation are also identified. Importantly, potential therapeutic targets are identified in 69% of the tumours.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.259
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3,055
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueNatureSame topicBladder and Urothelial Cancer TreatmentsFrench-language works237,207